Publicly available stock market data from sources like NASDAQ or Yahoo Finance

FDA Approves Elanco's Zenrelia™ for Dogs, Shares Up 2%

Sep 19, 2024, 07:18 PM

The U.S. Food and Drug Administration (FDA) has approved Elanco Animal Health's new skin disease treatment for dogs, Zenrelia™ (ilunocitinib tablets). This approval marks a significant advancement in canine dermatology, offering an effective and safe solution for treating skin conditions in dogs. The announcement has positively impacted Elanco's market performance, with the company's shares rising by 2% in afternoon trade.